ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Pediatric Vaccines - Global Market Insights and Sales Trends 2024
Published Date: November 2023
|
Report Code: QYRE-Auto-13M6952
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Pediatric Vaccines Market Insights and Forecast to 2028
BUY CHAPTERS

Pediatric Vaccines - Global Market Insights and Sales Trends 2024

Code: QYRE-Auto-13M6952
Report
November 2023
Pages:125
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
GlaxoSmithKline PLC
Merck
Pfizer Inc
Sanofi
Astrazeneca plc
Novartis
Takeda Pharmaceutical
Bavarian Nordic
Baxter
LG Life Sciences
Lupin Ltd
S.K. Chemicals
Mitsubishi Tanabe Pharma
Janssen
Shenzhen Kangtai Biological Products
SINOVAC BIOTECH
Bharat Biotech
Crucell
Dynavax
Serum Institute of India

Pediatric Vaccines - Market Size

The global Pediatric Vaccines market size is expected to reach US$ 45100 million by 2029, growing at a CAGR of 5.7% from 2023 to 2029.

Pediatric Vaccines - Market

Pediatric Vaccines - Market

The market is mainly driven by the significant applications of Pediatric Vaccines in various end use industries. The expanding demands from the Newborn, Infant, Child and Dolescent, are propelling Pediatric Vaccines market. Diphtheria, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Influenza segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Objectives

This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Pediatric Vaccines, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.

Key Features of The Study:

This report provides in-depth analysis of the global Pediatric Vaccines market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Pediatric Vaccines market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Pediatric Vaccines sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Pediatric Vaccines covered in this report include GlaxoSmithKline, Merck, Pfizer, Sanofi, AstraZeneca, Novartis, Takeda Pharmaceutical, Bavarian Nordic and Baxter, etc.
The global Pediatric Vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
GlaxoSmithKline
Merck
Pfizer
Sanofi
AstraZeneca
Novartis
Takeda Pharmaceutical
Bavarian Nordic
Baxter
LG Life Sciences
Lupin
S K Chemicals
Mitsubishi Tanabe Pharma
Janssen
Shenzhen Kangtai Biological Products
Sinovac Biotech
Bharat Biotech
Crucell
Dynavax
Serum Institute of India

Scope of Pediatric Vaccines - Market Report

Report Metric Details
Report Name Pediatric Vaccines - Market
Forecasted market size in 2029 US$ 45100 million
CAGR 5.7%
Forecasted years 2023 - 2029
Global Pediatric Vaccines market, by region:
  • North America (U.S., Canada, Mexico)
  • Europe (Germany, France, UK, Italy, etc.)
  • Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
  • South America (Brazil, etc.)
  • Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Pediatric Vaccines market, Segment by Type:
  • Diphtheria
  • Influenza
  • Hepatitis
  • Pneumococcal Diseases
  • Meningococcal Diseases
  • Others
Global Pediatric Vaccines market, by Application
  • Newborn
  • Infant
  • Child
  • Dolescent
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
  • Chapter Two: Detailed analysis of Pediatric Vaccines manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter Three: Sales, revenue of Pediatric Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
  • Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
  • Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
  • Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter Twelve: Analysis of sales channel, distributors and customers.
  • Chapter Thirteen: Research Findings and Conclusion.

FAQ for this report

What is the Pediatric Vaccines - Market size in 2029?

Ans: The Pediatric Vaccines - Market size in 2029 will be US$ 45100 million.

What are the Application segmentation covered in the Pediatric Vaccines - Market report?

Ans: The Applications covered in the Pediatric Vaccines - Market report are Newborn, Infant, Child, Dolescent

What are the Type segmentation covered in the Pediatric Vaccines - Market report?

Ans: The Types covered in the Pediatric Vaccines - Market report are Diphtheria, Influenza, Hepatitis, Pneumococcal Diseases, Meningococcal Diseases, Others

1 Pediatric Vaccines Market Overview
1.1 Pediatric Vaccines Product Overview
1.2 Pediatric Vaccines Market Segment by Type
1.2.1 Diphtheria
1.2.2 Influenza
1.2.3 Hepatitis
1.2.4 Pneumococcal Diseases
1.2.5 Meningococcal Diseases
1.2.6 Others
1.3 Global Pediatric Vaccines Market Size by Type
1.3.1 Global Pediatric Vaccines Market Size Overview by Type (2018-2029)
1.3.2 Global Pediatric Vaccines Historic Market Size Review by Type (2018-2023)
1.3.3 Global Pediatric Vaccines Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Pediatric Vaccines Sales Breakdown by Type (2018-2023)
1.4.2 Europe Pediatric Vaccines Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Pediatric Vaccines Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Pediatric Vaccines Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Pediatric Vaccines Sales Breakdown by Type (2018-2023)
2 Global Pediatric Vaccines Market Competition by Company
2.1 Global Top Players by Pediatric Vaccines Sales (2018-2023)
2.2 Global Top Players by Pediatric Vaccines Revenue (2018-2023)
2.3 Global Top Players by Pediatric Vaccines Price (2018-2023)
2.4 Global Top Manufacturers Pediatric Vaccines Manufacturing Base Distribution, Sales Area, Product Type
2.5 Pediatric Vaccines Market Competitive Situation and Trends
2.5.1 Pediatric Vaccines Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Pediatric Vaccines Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Pediatric Vaccines as of 2022)
2.7 Date of Key Manufacturers Enter into Pediatric Vaccines Market
2.8 Key Manufacturers Pediatric Vaccines Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Pediatric Vaccines Status and Outlook by Region
3.1 Global Pediatric Vaccines Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Pediatric Vaccines Historic Market Size by Region
3.2.1 Global Pediatric Vaccines Sales in Volume by Region (2018-2023)
3.2.2 Global Pediatric Vaccines Sales in Value by Region (2018-2023)
3.2.3 Global Pediatric Vaccines Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Pediatric Vaccines Forecasted Market Size by Region
3.3.1 Global Pediatric Vaccines Sales in Volume by Region (2024-2029)
3.3.2 Global Pediatric Vaccines Sales in Value by Region (2024-2029)
3.3.3 Global Pediatric Vaccines Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Pediatric Vaccines by Application
4.1 Pediatric Vaccines Market Segment by Application
4.1.1 Newborn
4.1.2 Infant
4.1.3 Child
4.1.4 Dolescent
4.2 Global Pediatric Vaccines Market Size by Application
4.2.1 Global Pediatric Vaccines Market Size Overview by Application (2018-2029)
4.2.2 Global Pediatric Vaccines Historic Market Size Review by Application (2018-2023)
4.2.3 Global Pediatric Vaccines Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Pediatric Vaccines Sales Breakdown by Application (2018-2023)
4.3.2 Europe Pediatric Vaccines Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Pediatric Vaccines Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Pediatric Vaccines Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Pediatric Vaccines Sales Breakdown by Application (2018-2023)
5 North America Pediatric Vaccines by Country
5.1 North America Pediatric Vaccines Historic Market Size by Country
5.1.1 North America Pediatric Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Pediatric Vaccines Sales in Volume by Country (2018-2023)
5.1.3 North America Pediatric Vaccines Sales in Value by Country (2018-2023)
5.2 North America Pediatric Vaccines Forecasted Market Size by Country
5.2.1 North America Pediatric Vaccines Sales in Volume by Country (2024-2029)
5.2.2 North America Pediatric Vaccines Sales in Value by Country (2024-2029)
6 Europe Pediatric Vaccines by Country
6.1 Europe Pediatric Vaccines Historic Market Size by Country
6.1.1 Europe Pediatric Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Pediatric Vaccines Sales in Volume by Country (2018-2023)
6.1.3 Europe Pediatric Vaccines Sales in Value by Country (2018-2023)
6.2 Europe Pediatric Vaccines Forecasted Market Size by Country
6.2.1 Europe Pediatric Vaccines Sales in Volume by Country (2024-2029)
6.2.2 Europe Pediatric Vaccines Sales in Value by Country (2024-2029)
7 Asia-Pacific Pediatric Vaccines by Region
7.1 Asia-Pacific Pediatric Vaccines Historic Market Size by Region
7.1.1 Asia-Pacific Pediatric Vaccines Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Pediatric Vaccines Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Pediatric Vaccines Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Pediatric Vaccines Forecasted Market Size by Region
7.2.1 Asia-Pacific Pediatric Vaccines Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Pediatric Vaccines Sales in Value by Region (2024-2029)
8 Latin America Pediatric Vaccines by Country
8.1 Latin America Pediatric Vaccines Historic Market Size by Country
8.1.1 Latin America Pediatric Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Pediatric Vaccines Sales in Volume by Country (2018-2023)
8.1.3 Latin America Pediatric Vaccines Sales in Value by Country (2018-2023)
8.2 Latin America Pediatric Vaccines Forecasted Market Size by Country
8.2.1 Latin America Pediatric Vaccines Sales in Volume by Country (2024-2029)
8.2.2 Latin America Pediatric Vaccines Sales in Value by Country (2024-2029)
9 Middle East and Africa Pediatric Vaccines by Country
9.1 Middle East and Africa Pediatric Vaccines Historic Market Size by Country
9.1.1 Middle East and Africa Pediatric Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Pediatric Vaccines Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Pediatric Vaccines Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Pediatric Vaccines Forecasted Market Size by Country
9.2.1 Middle East and Africa Pediatric Vaccines Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Pediatric Vaccines Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 GlaxoSmithKline
10.1.1 GlaxoSmithKline Company Information
10.1.2 GlaxoSmithKline Introduction and Business Overview
10.1.3 GlaxoSmithKline Pediatric Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.1.4 GlaxoSmithKline Pediatric Vaccines Products Offered
10.1.5 GlaxoSmithKline Recent Development
10.2 Merck
10.2.1 Merck Company Information
10.2.2 Merck Introduction and Business Overview
10.2.3 Merck Pediatric Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Merck Pediatric Vaccines Products Offered
10.2.5 Merck Recent Development
10.3 Pfizer
10.3.1 Pfizer Company Information
10.3.2 Pfizer Introduction and Business Overview
10.3.3 Pfizer Pediatric Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Pfizer Pediatric Vaccines Products Offered
10.3.5 Pfizer Recent Development
10.4 Sanofi
10.4.1 Sanofi Company Information
10.4.2 Sanofi Introduction and Business Overview
10.4.3 Sanofi Pediatric Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Sanofi Pediatric Vaccines Products Offered
10.4.5 Sanofi Recent Development
10.5 AstraZeneca
10.5.1 AstraZeneca Company Information
10.5.2 AstraZeneca Introduction and Business Overview
10.5.3 AstraZeneca Pediatric Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.5.4 AstraZeneca Pediatric Vaccines Products Offered
10.5.5 AstraZeneca Recent Development
10.6 Novartis
10.6.1 Novartis Company Information
10.6.2 Novartis Introduction and Business Overview
10.6.3 Novartis Pediatric Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Novartis Pediatric Vaccines Products Offered
10.6.5 Novartis Recent Development
10.7 Takeda Pharmaceutical
10.7.1 Takeda Pharmaceutical Company Information
10.7.2 Takeda Pharmaceutical Introduction and Business Overview
10.7.3 Takeda Pharmaceutical Pediatric Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Takeda Pharmaceutical Pediatric Vaccines Products Offered
10.7.5 Takeda Pharmaceutical Recent Development
10.8 Bavarian Nordic
10.8.1 Bavarian Nordic Company Information
10.8.2 Bavarian Nordic Introduction and Business Overview
10.8.3 Bavarian Nordic Pediatric Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Bavarian Nordic Pediatric Vaccines Products Offered
10.8.5 Bavarian Nordic Recent Development
10.9 Baxter
10.9.1 Baxter Company Information
10.9.2 Baxter Introduction and Business Overview
10.9.3 Baxter Pediatric Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Baxter Pediatric Vaccines Products Offered
10.9.5 Baxter Recent Development
10.10 LG Life Sciences
10.10.1 LG Life Sciences Company Information
10.10.2 LG Life Sciences Introduction and Business Overview
10.10.3 LG Life Sciences Pediatric Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.10.4 LG Life Sciences Pediatric Vaccines Products Offered
10.10.5 LG Life Sciences Recent Development
10.11 Lupin
10.11.1 Lupin Company Information
10.11.2 Lupin Introduction and Business Overview
10.11.3 Lupin Pediatric Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Lupin Pediatric Vaccines Products Offered
10.11.5 Lupin Recent Development
10.12 S K Chemicals
10.12.1 S K Chemicals Company Information
10.12.2 S K Chemicals Introduction and Business Overview
10.12.3 S K Chemicals Pediatric Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.12.4 S K Chemicals Pediatric Vaccines Products Offered
10.12.5 S K Chemicals Recent Development
10.13 Mitsubishi Tanabe Pharma
10.13.1 Mitsubishi Tanabe Pharma Company Information
10.13.2 Mitsubishi Tanabe Pharma Introduction and Business Overview
10.13.3 Mitsubishi Tanabe Pharma Pediatric Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Mitsubishi Tanabe Pharma Pediatric Vaccines Products Offered
10.13.5 Mitsubishi Tanabe Pharma Recent Development
10.14 Janssen
10.14.1 Janssen Company Information
10.14.2 Janssen Introduction and Business Overview
10.14.3 Janssen Pediatric Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.14.4 Janssen Pediatric Vaccines Products Offered
10.14.5 Janssen Recent Development
10.15 Shenzhen Kangtai Biological Products
10.15.1 Shenzhen Kangtai Biological Products Company Information
10.15.2 Shenzhen Kangtai Biological Products Introduction and Business Overview
10.15.3 Shenzhen Kangtai Biological Products Pediatric Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.15.4 Shenzhen Kangtai Biological Products Pediatric Vaccines Products Offered
10.15.5 Shenzhen Kangtai Biological Products Recent Development
10.16 Sinovac Biotech
10.16.1 Sinovac Biotech Company Information
10.16.2 Sinovac Biotech Introduction and Business Overview
10.16.3 Sinovac Biotech Pediatric Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.16.4 Sinovac Biotech Pediatric Vaccines Products Offered
10.16.5 Sinovac Biotech Recent Development
10.17 Bharat Biotech
10.17.1 Bharat Biotech Company Information
10.17.2 Bharat Biotech Introduction and Business Overview
10.17.3 Bharat Biotech Pediatric Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.17.4 Bharat Biotech Pediatric Vaccines Products Offered
10.17.5 Bharat Biotech Recent Development
10.18 Crucell
10.18.1 Crucell Company Information
10.18.2 Crucell Introduction and Business Overview
10.18.3 Crucell Pediatric Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.18.4 Crucell Pediatric Vaccines Products Offered
10.18.5 Crucell Recent Development
10.19 Dynavax
10.19.1 Dynavax Company Information
10.19.2 Dynavax Introduction and Business Overview
10.19.3 Dynavax Pediatric Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.19.4 Dynavax Pediatric Vaccines Products Offered
10.19.5 Dynavax Recent Development
10.20 Serum Institute of India
10.20.1 Serum Institute of India Company Information
10.20.2 Serum Institute of India Introduction and Business Overview
10.20.3 Serum Institute of India Pediatric Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.20.4 Serum Institute of India Pediatric Vaccines Products Offered
10.20.5 Serum Institute of India Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Pediatric Vaccines Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Pediatric Vaccines Industrial Chain Analysis
11.4 Pediatric Vaccines Market Dynamics
11.4.1 Pediatric Vaccines Industry Trends
11.4.2 Pediatric Vaccines Market Drivers
11.4.3 Pediatric Vaccines Market Challenges
11.4.4 Pediatric Vaccines Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Pediatric Vaccines Distributors
12.3 Pediatric Vaccines Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
FEATURED COMPANIES
GlaxoSmithKline PLC
Merck
Pfizer Inc
Sanofi
Astrazeneca plc
Novartis
Takeda Pharmaceutical
Bavarian Nordic
Baxter
LG Life Sciences
Lupin Ltd
S.K. Chemicals
Mitsubishi Tanabe Pharma
Janssen
Shenzhen Kangtai Biological Products
SINOVAC BIOTECH
Bharat Biotech
Crucell
Dynavax
Serum Institute of India
List of Tables
    Table 1. Major Company of Diphtheria
    Table 2. Major Company of Influenza
    Table 3. Major Company of Hepatitis
    Table 4. Major Company of Pneumococcal Diseases
    Table 5. Major Company of Meningococcal Diseases
    Table 6. Major Company of Others
    Table 7. Global Pediatric Vaccines Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
    Table 8. Global Pediatric Vaccines Sales by Type (2018-2023) & (K Units)
    Table 9. Global Pediatric Vaccines Sales Market Share in Volume by Type (2018-2023)
    Table 10. Global Pediatric Vaccines Sales by Type (2018-2023) & (US& Million)
    Table 11. Global Pediatric Vaccines Market Share in Value by Type (2018-2023)
    Table 12. Global Pediatric Vaccines Price by Type (2018-2023) & (USD/Unit)
    Table 13. Global Pediatric Vaccines Sales by Type (2024-2029) & (K Units)
    Table 14. Global Pediatric Vaccines Sales Market Share in Volume by Type (2024-2029)
    Table 15. Global Pediatric Vaccines Sales by Type (2024-2029) & (US$ Million)
    Table 16. Global Pediatric Vaccines Sales Market Share in Value by Type (2024-2029)
    Table 17. Global Pediatric Vaccines Price by Type (2024-2029) & (USD/Unit)
    Table 18. North America Pediatric Vaccines Sales by Type (2018-2023) & (K Units)
    Table 19. North America Pediatric Vaccines Sales by Type (2018-2023) & (US$ Million)
    Table 20. Europe Pediatric Vaccines Sales (K Units) by Type (2018-2023)
    Table 21. Europe Pediatric Vaccines Sales by Type (2018-2023) & (US$ Million)
    Table 22. Asia-Pacific Pediatric Vaccines Sales (K Units) by Type (2018-2023)
    Table 23. Asia-Pacific Pediatric Vaccines Sales by Type (2018-2023) & (US$ Million)
    Table 24. Latin America Pediatric Vaccines Sales (K Units) by Type (2018-2023)
    Table 25. Latin America Pediatric Vaccines Sales by Type (2018-2023) & (US$ Million)
    Table 26. Middle East and Africa Pediatric Vaccines Sales (K Units) by Type (2018-2023)
    Table 27. Middle East and Africa Pediatric Vaccines Sales by Type (2018-2023) & (US$ Million)
    Table 28. Global Pediatric Vaccines Sales by Company (2018-2023) & (K Units)
    Table 29. Global Pediatric Vaccines Sales Share by Company (2018-2023)
    Table 30. Global Pediatric Vaccines Revenue by Company (2018-2023) & (US$ Million)
    Table 31. Global Pediatric Vaccines Revenue Share by Company (2018-2023)
    Table 32. Global Market Pediatric Vaccines Price by Company (2018-2023) & (USD/Unit)
    Table 33. Global Pediatric Vaccines Top Manufacturers Manufacturing Base Distribution and Sales Area
    Table 34. Global Pediatric Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 35. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Pediatric Vaccines as of 2022)
    Table 36. Date of Key Manufacturers Enter into Pediatric Vaccines Market
    Table 37. Key Manufacturers Pediatric Vaccines Product Type
    Table 38. Mergers & Acquisitions, Expansion Plans
    Table 39. Global Pediatric Vaccines Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 40. Global Pediatric Vaccines Sales by Region (2018-2023) & (K Units)
    Table 41. Global Pediatric Vaccines Sales Market Share in Volume by Region (2018-2023)
    Table 42. Global Pediatric Vaccines Sales by Region (2018-2023) & (US$ Million)
    Table 43. Global Pediatric Vaccines Sales Market Share in Value by Region (2018-2023)
    Table 44. Global Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 45. Global Pediatric Vaccines Sales by Region (2024-2029) & (K Units)
    Table 46. Global Pediatric Vaccines Sales Market Share in Volume by Region (2024-2029)
    Table 47. Global Pediatric Vaccines Sales by Region (2024-2029) & (US$ Million)
    Table 48. Global Pediatric Vaccines Sales Market Share in Value by Region (2024-2029)
    Table 49. Global Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2029)
    Table 50. Global Pediatric Vaccines Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
    Table 51. Global Pediatric Vaccines Sales by Application (2018-2023) & (K Units)
    Table 52. Global Pediatric Vaccines Sales Market Share in Volume by Application (2018-2023)
    Table 53. Global Pediatric Vaccines Sales by Application (2018-2023) & (US$ Million)
    Table 54. Global Pediatric Vaccines Sales Market Share in Value by Application (2018-2023)
    Table 55. Global Pediatric Vaccines Price by Application (2018-2023) & (USD/Unit)
    Table 56. Global Pediatric Vaccines Sales by Application (2024-2029) & (K Units)
    Table 57. Global Pediatric Vaccines Sales Market Share in Volume by Application (2024-2029)
    Table 58. Global Pediatric Vaccines Sales by Application (2024-2029) & (US$ Million)
    Table 59. Global Pediatric Vaccines Sales Market Share in Value by Application (2024-2029)
    Table 60. Global Pediatric Vaccines Price by Application (2024-2029) & (USD/Unit)
    Table 61. North America Pediatric Vaccines Sales by Application (2018-2023) (K Units)
    Table 62. North America Pediatric Vaccines Sales by Application (2018-2023) & (US$ Million)
    Table 63. Europe Pediatric Vaccines Sales by Application (2018-2023) (K Units)
    Table 64. Europe Pediatric Vaccines Sales by Application (2018-2023) & (US$ Million)
    Table 65. Asia-Pacific Pediatric Vaccines Sales by Application (2018-2023) (K Units)
    Table 66. Asia-Pacific Pediatric Vaccines Sales by Application (2018-2023) & (US$ Million)
    Table 67. Latin America Pediatric Vaccines Sales by Application (2018-2023) (K Units)
    Table 68. Latin America Pediatric Vaccines Sales by Application (2018-2023) & (US$ Million)
    Table 69. Middle East and Africa Pediatric Vaccines Sales by Application (2018-2023) (K Units)
    Table 70. Middle East and Africa Pediatric Vaccines Sales by Application (2018-2023) & (US$ Million)
    Table 71. North America Pediatric Vaccines Sales by Country (2018-2023) & (K Units)
    Table 72. North America Pediatric Vaccines Sales Market Share in Volume by Country (2018-2023)
    Table 73. North America Pediatric Vaccines Sales by Country (2018-2023) & (US$ Million)
    Table 74. North America Pediatric Vaccines Sales Market Share in Value by Country (2018-2023)
    Table 75. North America Pediatric Vaccines Sales by Country (2024-2029) & (K Units)
    Table 76. North America Pediatric Vaccines Sales Market Share in Volume by Country (2024-2029)
    Table 77. North America Pediatric Vaccines Sales by Country (2024-2029) & (US$ Million)
    Table 78. North America Pediatric Vaccines Sales Market Share in Value by Country (2024-2029)
    Table 79. Europe Pediatric Vaccines Sales by Country (2018-2023) & (K Units)
    Table 80. Europe Pediatric Vaccines Sales Market Share in Volume by Country (2018-2023)
    Table 81. Europe Pediatric Vaccines Sales by Country (2018-2023) & (US$ Million)
    Table 82. Europe Pediatric Vaccines Sales Market Share in Value by Country (2018-2023)
    Table 83. Europe Pediatric Vaccines Sales by Country (2024-2029) & (K Units)
    Table 84. Europe Pediatric Vaccines Sales Market Share in Volume by Country (2024-2029)
    Table 85. Europe Pediatric Vaccines Sales by Country (2024-2029) & (US$ Million)
    Table 86. Europe Pediatric Vaccines Sales Market Share in Value by Country (2024-2029)
    Table 87. Asia-Pacific Pediatric Vaccines Sales by Region (2018-2023) & (K Units)
    Table 88. Asia-Pacific Pediatric Vaccines Sales Market Share in Volume by Region (2018-2023)
    Table 89. Asia-Pacific Pediatric Vaccines Sales by Region (2018-2023) & (US$ Million)
    Table 90. Asia-Pacific Pediatric Vaccines Sales Market Share in Value by Region (2018-2023)
    Table 91. Asia-Pacific Pediatric Vaccines Sales by Region (2024-2029) & (K Units)
    Table 92. Asia-Pacific Pediatric Vaccines Sales Market Share in Volume by Region (2024-2029)
    Table 93. Asia-Pacific Pediatric Vaccines Sales by Region (2024-2029) & (US$ Million)
    Table 94. Asia-Pacific Pediatric Vaccines Sales Market Share in Value by Region (2024-2029)
    Table 95. Latin America Pediatric Vaccines Sales by Country (2018-2023) & (K Units)
    Table 96. Latin America Pediatric Vaccines Sales Market Share in Volume by Country (2018-2023)
    Table 97. Latin America Pediatric Vaccines Sales by Country (2018-2023) & (US$ Million)
    Table 98. Latin America Pediatric Vaccines Sales Market Share in Value by Country (2018-2023)
    Table 99. Latin America Pediatric Vaccines Sales by Country (2024-2029) & (K Units)
    Table 100. Latin America Pediatric Vaccines Sales Market Share in Volume by Country (2024-2029)
    Table 101. Latin America Pediatric Vaccines Sales by Country (2024-2029) & (US$ Million)
    Table 102. Latin America Pediatric Vaccines Sales Market Share in Value by Country (2024-2029)
    Table 103. Middle East and Africa Pediatric Vaccines Sales by Country (2018-2023) & (K Units)
    Table 104. Middle East and Africa Pediatric Vaccines Sales Market Share in Volume by Country (2018-2023)
    Table 105. Middle East and Africa Pediatric Vaccines Sales by Country (2018-2023) & (US$ Million)
    Table 106. Middle East and Africa Pediatric Vaccines Sales Market Share in Value by Country (2018-2023)
    Table 107. Middle East and Africa Pediatric Vaccines Sales by Country (2024-2029) & (K Units)
    Table 108. Middle East and Africa Pediatric Vaccines Sales Market Share in Volume by Country (2024-2029)
    Table 109. Middle East and Africa Pediatric Vaccines Sales by Country (2024-2029) & (US$ Million)
    Table 110. Middle East and Africa Pediatric Vaccines Sales Market Share in Value by Country (2024-2029)
    Table 111. GlaxoSmithKline Company Information
    Table 112. GlaxoSmithKline Introduction and Business Overview
    Table 113. GlaxoSmithKline Pediatric Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 114. GlaxoSmithKline Pediatric Vaccines Product
    Table 115. GlaxoSmithKline Recent Development
    Table 116. Merck Company Information
    Table 117. Merck Introduction and Business Overview
    Table 118. Merck Pediatric Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 119. Merck Pediatric Vaccines Product
    Table 120. Merck Recent Development
    Table 121. Pfizer Company Information
    Table 122. Pfizer Introduction and Business Overview
    Table 123. Pfizer Pediatric Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 124. Pfizer Pediatric Vaccines Product
    Table 125. Pfizer Recent Development
    Table 126. Sanofi Company Information
    Table 127. Sanofi Introduction and Business Overview
    Table 128. Sanofi Pediatric Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 129. Sanofi Pediatric Vaccines Product
    Table 130. Sanofi Recent Development
    Table 131. AstraZeneca Company Information
    Table 132. AstraZeneca Introduction and Business Overview
    Table 133. AstraZeneca Pediatric Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 134. AstraZeneca Pediatric Vaccines Product
    Table 135. AstraZeneca Recent Development
    Table 136. Novartis Company Information
    Table 137. Novartis Introduction and Business Overview
    Table 138. Novartis Pediatric Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 139. Novartis Pediatric Vaccines Product
    Table 140. Novartis Recent Development
    Table 141. Takeda Pharmaceutical Company Information
    Table 142. Takeda Pharmaceutical Introduction and Business Overview
    Table 143. Takeda Pharmaceutical Pediatric Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 144. Takeda Pharmaceutical Pediatric Vaccines Product
    Table 145. Takeda Pharmaceutical Recent Development
    Table 146. Bavarian Nordic Company Information
    Table 147. Bavarian Nordic Introduction and Business Overview
    Table 148. Bavarian Nordic Pediatric Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 149. Bavarian Nordic Pediatric Vaccines Product
    Table 150. Bavarian Nordic Recent Development
    Table 151. Baxter Company Information
    Table 152. Baxter Introduction and Business Overview
    Table 153. Baxter Pediatric Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 154. Baxter Pediatric Vaccines Product
    Table 155. Baxter Recent Development
    Table 156. LG Life Sciences Company Information
    Table 157. LG Life Sciences Introduction and Business Overview
    Table 158. LG Life Sciences Pediatric Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 159. LG Life Sciences Pediatric Vaccines Product
    Table 160. LG Life Sciences Recent Development
    Table 161. Lupin Company Information
    Table 162. Lupin Introduction and Business Overview
    Table 163. Lupin Pediatric Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 164. Lupin Pediatric Vaccines Product
    Table 165. Lupin Recent Development
    Table 166. S K Chemicals Company Information
    Table 167. S K Chemicals Introduction and Business Overview
    Table 168. S K Chemicals Pediatric Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 169. S K Chemicals Pediatric Vaccines Product
    Table 170. S K Chemicals Recent Development
    Table 171. Mitsubishi Tanabe Pharma Company Information
    Table 172. Mitsubishi Tanabe Pharma Introduction and Business Overview
    Table 173. Mitsubishi Tanabe Pharma Pediatric Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 174. Mitsubishi Tanabe Pharma Pediatric Vaccines Product
    Table 175. Mitsubishi Tanabe Pharma Recent Development
    Table 176. Janssen Company Information
    Table 177. Janssen Introduction and Business Overview
    Table 178. Janssen Pediatric Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 179. Janssen Pediatric Vaccines Product
    Table 180. Janssen Recent Development
    Table 181. Shenzhen Kangtai Biological Products Company Information
    Table 182. Shenzhen Kangtai Biological Products Introduction and Business Overview
    Table 183. Shenzhen Kangtai Biological Products Pediatric Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 184. Shenzhen Kangtai Biological Products Pediatric Vaccines Product
    Table 185. Shenzhen Kangtai Biological Products Recent Development
    Table 186. Sinovac Biotech Company Information
    Table 187. Sinovac Biotech Introduction and Business Overview
    Table 188. Sinovac Biotech Pediatric Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 189. Sinovac Biotech Pediatric Vaccines Product
    Table 190. Sinovac Biotech Recent Development
    Table 191. Bharat Biotech Company Information
    Table 192. Bharat Biotech Introduction and Business Overview
    Table 193. Bharat Biotech Pediatric Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 194. Bharat Biotech Pediatric Vaccines Product
    Table 195. Bharat Biotech Recent Development
    Table 196. Crucell Company Information
    Table 197. Crucell Introduction and Business Overview
    Table 198. Crucell Pediatric Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 199. Crucell Pediatric Vaccines Product
    Table 200. Crucell Recent Development
    Table 201. Dynavax Company Information
    Table 202. Dynavax Introduction and Business Overview
    Table 203. Dynavax Pediatric Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 204. Dynavax Pediatric Vaccines Product
    Table 205. Dynavax Recent Development
    Table 206. Serum Institute of India Company Information
    Table 207. Serum Institute of India Introduction and Business Overview
    Table 208. Serum Institute of India Pediatric Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 209. Serum Institute of India Pediatric Vaccines Product
    Table 210. Serum Institute of India Recent Development
    Table 211. Key Raw Materials Lists
    Table 212. Raw Materials Key Suppliers Lists
    Table 213. Pediatric Vaccines Market Trends
    Table 214. Pediatric Vaccines Market Drivers
    Table 215. Pediatric Vaccines Market Challenges
    Table 216. Pediatric Vaccines Market Restraints
    Table 217. Pediatric Vaccines Distributors List
    Table 218. Pediatric Vaccines Downstream Customers
    Table 219. Research Programs/Design for This Report
    Table 220. Key Data Information from Secondary Sources
    Table 221. Key Data Information from Primary Sources
List of Figures
    Figure 1. Pediatric Vaccines Product Picture
    Figure 2. Global Pediatric Vaccines Market Size, 2018 VS 2022 VS 2029 (US$ Million)
    Figure 3. Global Pediatric Vaccines Market Size Status and Outlook (2018-2029) & (US$ Million)
    Figure 4. Global Pediatric Vaccines Sales Status and Outlook (2018-2029) & (K Units)
    Figure 5. Product Picture of Diphtheria
    Figure 6. Global Diphtheria Sales YoY Growth (2018-2029) & (K Units)
    Figure 7. Product Picture of Influenza
    Figure 8. Global Influenza Sales YoY Growth (2018-2029) & (K Units)
    Figure 9. Product Picture of Hepatitis
    Figure 10. Global Hepatitis Sales YoY Growth (2018-2029) & (K Units)
    Figure 11. Product Picture of Pneumococcal Diseases
    Figure 12. Global Pneumococcal Diseases Sales YoY Growth (2018-2029) & (K Units)
    Figure 13. Product Picture of Meningococcal Diseases
    Figure 14. Global Meningococcal Diseases Sales YoY Growth (2018-2029) & (K Units)
    Figure 15. Product Picture of Others
    Figure 16. Global Others Sales YoY Growth (2018-2029) & (K Units)
    Figure 17. Global Pediatric Vaccines Sales by Type (2018-2029) & (US$ Million)
    Figure 18. Global Pediatric Vaccines Sales Market Share by Type in 2022 & 2029
    Figure 19. North America Pediatric Vaccines Sales Market Share in Volume by Type in 2022
    Figure 20. North America Pediatric Vaccines Sales Market Share in Value by Type in 2022
    Figure 21. Europe Pediatric Vaccines Sales Market Share in Volume by Type in 2022
    Figure 22. Europe Pediatric Vaccines Sales Market Share in Value by Type in 2022
    Figure 23. Asia-Pacific Pediatric Vaccines Sales Market Share in Volume by Type in 2022
    Figure 24. Asia-Pacific Pediatric Vaccines Sales Market Share in Value by Type in 2022
    Figure 25. Latin America Pediatric Vaccines Sales Market Share in Volume by Type in 2022
    Figure 26. Latin America Pediatric Vaccines Sales Market Share in Value by Type in 2022
    Figure 27. Middle East and Africa Pediatric Vaccines Sales Market Share in Volume by Type in 2022
    Figure 28. Middle East and Africa Pediatric Vaccines Sales Market Share in Value by Type in 2022
    Figure 29. The 5 and 10 Largest Manufacturers in the World: Market Share by Pediatric Vaccines Sales in 2022
    Figure 30. The 5 and 10 Largest Manufacturers in the World: Market Share by Pediatric Vaccines Revenue in 2022
    Figure 31. Pediatric Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
    Figure 32. Product Picture of Newborn
    Figure 33. Global Newborn Sales YoY Growth (2018-2029) & (K Units)
    Figure 34. Product Picture of Infant
    Figure 35. Global Infant Sales YoY Growth (2018-2029) & (K Units)
    Figure 36. Product Picture of Child
    Figure 37. Global Child Sales YoY Growth (2018-2029) & (K Units)
    Figure 38. Product Picture of Dolescent
    Figure 39. Global Dolescent Sales YoY Growth (2018-2029) & (K Units)
    Figure 40. Global Pediatric Vaccines Sales by Application (2018-2029) & (US$ Million)
    Figure 41. Global Pediatric Vaccines Sales Market Share by Application in 2022 & 2029
    Figure 42. North America Pediatric Vaccines Sales Market Share in Volume by Application in 2022
    Figure 43. North America Pediatric Vaccines Sales Market Share in Value by Application in 2022
    Figure 44. Europe Pediatric Vaccines Sales Market Share in Volume by Application in 2022
    Figure 45. Europe Pediatric Vaccines Sales Market Share in Value by Application in 2022
    Figure 46. Asia-Pacific Pediatric Vaccines Sales Market Share in Volume by Application in 2022
    Figure 47. Asia-Pacific Pediatric Vaccines Sales Market Share in Value by Application in 2022
    Figure 48. Latin America Pediatric Vaccines Sales Market Share in Volume by Application in 2022
    Figure 49. Latin America Pediatric Vaccines Sales Market Share in Value by Application in 2022
    Figure 50. Middle East and Africa Pediatric Vaccines Sales Market Share in Value by Application in 2022
    Figure 51. Key Raw Materials Price
    Figure 52. Pediatric Vaccines Manufacturing Cost Structure
    Figure 53. Pediatric Vaccines Industrial Chain Analysis
    Figure 54. Channels of Distribution
    Figure 55. Distributors Profiles
    Figure 56. Bottom-up and Top-down Approaches for This Report
    Figure 57. Data Triangulation
    Figure 58. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3350

This license allows only one user to access the PDF.
Electronic (PDF)

$5025

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$6700

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions